177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors
177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors
Recruiting · NCT06632873 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors | SSTR2 and Integrin αVβ3 Positive Tumors | Recruiting | Early phase 1 | 2024-10-15 | NCT06632873 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking Union Medical College Hospital | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Science & Peking Union Medical College Hospital | Beijing | China | 3 |